Invention Grant
- Patent Title: Biomarkers for determining breast cancer bone metastasis
- Patent Title (中): 用于确定乳腺癌骨转移的生物标志物
-
Application No.: US13825760Application Date: 2011-09-22
-
Publication No.: US09362094B2Publication Date: 2016-06-07
- Inventor: Larry Suva , Stephanie Byrum , Charity Washam
- Applicant: Larry Suva , Stephanie Byrum , Charity Washam
- Applicant Address: US AR Little Rock
- Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
- Current Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
- Current Assignee Address: US AR Little Rock
- Agency: Polsinelli PC
- International Application: PCT/US2011/052737 WO 20110922
- International Announcement: WO2012/040447 WO 20120329
- Main IPC: G01N33/574
- IPC: G01N33/574 ; G01N33/68 ; H01J49/00
Abstract:
The invention provides biomarkers and biomarker profiles that discriminate between a subject with breast cancer that has metastasized to the bone and a subject with breast cancer that has not metastasized to the bone. In particular, the biomarker and biomarker profile include polypeptides present or present at higher levels in the circulatory system of subjects having breast cancer bone metastasis compared to subjects having breast cancer without bone metastasis.
Public/Granted literature
- US20130260399A1 BIOMARKERS FOR DETERMINING BREAST CANCER BONE METASTASIS Public/Granted day:2013-10-03
Information query
IPC分类:
